Stephen is the inventor of Sonosa’s therapeutic technology, and has successfully raised and managed $3.35M in R&D funding for Sonosa. Dr. Restaino has grown Sonosa from a nascent research project to a company with 8 employees. Prior to founding Sonosa, he published work on portable diagnostic technologies and therapeutic nerve stimulation devices; he also has experience designing and running human and animal research trials on medical devices.